PHIL Embolization for Chronic Subdural Hematoma Treatment
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a new minimally invasive procedure using PHIL, a liquid embolic agent, to treat chronic subdural hematoma—bleeding on the brain that develops slowly over weeks. Instead of surgery, doctors inject PHIL into the middle meningeal artery to reduce bleeding and relieve symptoms like headaches, dizziness, or weakness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 22 or older
- Diagnosed with chronic subdural hematoma (bleeding on brain, at least 10mm thick) causing symptoms
- Brain imaging shows signs of chronic bleeding (not fresh injury)
- Not pregnant (if female of childbearing age)
- Able to attend all follow-up visits as required
- No prior brain surgery or embolization on the affected side
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
This study follows patients with chronic subdural hematoma (a type of bleeding around the brain) who receive a procedure called middle meningeal artery embolization, which reduces blood flow to prevent rebleeding. Researchers will track your recovery with imaging and clinical assessments to understand how well this treatment works.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a procedure called middle meningeal artery embolization to treat chronic subdural hematoma (a slow blood collection on the brain). It's for people living in Puerto Rico who haven't had prior treatment for this condition.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial compares two ways to treat a chronic subdural hematoma (a long-lasting bleed between the brain and its covering): blocking a specific artery versus standard surgery to remove the blood. It may help you and your care team choose the safer and more effective option for your situation.
Hear when a new Chronic Subdural Hematomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.